Search Results - "Isaac Quiros-Fernandez"
-
1
Dual T cell receptor/chimeric antigen receptor engineered NK‐92 cells targeting the HPV16 E6 oncoprotein and the tumor‐associated antigen L1CAM exhibit enhanced cytotoxicity and specificity against tumor cells
Published in Journal of medical virology (01-05-2024)“…The human papillomavirus type 16 (HPV16) causes a large fraction of genital and oropharyngeal carcinomas. To maintain the transformed state, the tumor cells…”
Get full text
Journal Article -
2
Sphingolipid pathway as a biosensor of cancer chemosensitivity: a proof of principle
Published in Uniciencia (01-11-2022)“…Cancer is a complex genetic disease with reduced treatment alternatives due to tumor heterogeneity and drug multiresistance emergence. The sphingolipid (SL)…”
Get full text
Journal Article -
3
Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals
Published in EBioMedicine (01-10-2021)“…Recent studies have provided evidence of T cell reactivity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in significant numbers of…”
Get full text
Journal Article -
4
Perturbation-Based Modeling Unveils the Autophagic Modulation of Chemosensitivity and Immunogenicity in Breast Cancer Cells
Published in Metabolites (18-09-2021)“…In the absence of new therapeutic strategies, chemotherapeutic drugs are the most widely used strategy against metastatic breast cancer, in spite of eliciting…”
Get full text
Journal Article -
5
A costimulatory chimeric antigen receptor targeting TROP2 enhances the cytotoxicity of NK cells expressing a T cell receptor reactive to human papillomavirus type 16 E7
Published in Cancer letters (10-07-2023)“…Immune cells modified to express a tumor-reactive T cell receptor (TCR) have shown limited efficacy as stand-alone therapy against solid tumors. Genital and…”
Get full text
Journal Article -
6
Generation of CAR-T cells using lentiviral vectors
Published in Methods in cell biology (2022)“…Cancer immunotherapy is nowadays largely focused on the development of therapeutic antibodies and chimeric antigen receptors (CARs). Two CARs targeting CD19…”
Get full text
Journal Article